{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:44:39Z","timestamp":1792176279615,"version":"4.4.0"},"reference-count":44,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Bergen Medical Research Fund","award":["No award\/grant number"],"award-info":[{"award-number":["No award\/grant number"]}]},{"DOI":"10.13039\/501100004257","name":"Helse-Vest","doi-asserted-by":"crossref","award":["No award\/grant number"],"award-info":[{"award-number":["No award\/grant number"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2024,1,8]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The lower airway microbiota in patients with chronic obstructive pulmonary disease (COPD) are likely altered compared with the microbiota in healthy individuals. Information on how the microbiota is affected by smoking, use of inhaled corticosteroids (ICS) and COPD severity is still scarce.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In the MicroCOPD Study, participant characteristics were obtained through standardised questionnaires and clinical measurements at a single centre from 2012 to 2015. Protected bronchoalveolar lavage samples from 97 patients with COPD and 97 controls were paired-end sequenced with the Illumina MiSeq System. Data were analysed in QIIME 2 and R.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Alpha-diversity was lower in patients with COPD than controls (Pielou evenness: COPD=0.76, control=0.80, p=0.004; Shannon entropy: COPD=3.98, control=4.34, p=0.01). Beta-diversity differed with smoking only in the COPD cohort (weighted UniFrac: permutational analysis of variance R<jats:sup>2<\/jats:sup>=0.04, p=0.03). Nine genera were differentially abundant between COPD and controls. Genera enriched in COPD belonged to the<jats:italic>Firmicutes<\/jats:italic>phylum. Pack years were linked to differential abundance of taxa in controls only (ANCOM-BC (Analysis of Compositions of Microbiomes with Bias Correction) log-fold difference\/q-values:<jats:italic>Haemophilus<\/jats:italic>\u22120.05\/0.048;<jats:italic>Lachnoanaerobaculum<\/jats:italic>\u22120.04\/0.03).<jats:italic>Oribacterium<\/jats:italic>was absent in smoking patients with COPD compared with non-smoking patients (ANCOM-BC log-fold difference\/q-values: \u22121.46\/0.03). We found no associations between the microbiota and COPD severity or ICS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The lower airway microbiota is equal in richness in patients with COPD to controls, but less even. Genera from the<jats:italic>Firmicutes<\/jats:italic>phylum thrive particularly in COPD airways. Smoking has different effects on diversity and taxonomic abundance in patients with COPD compared with controls. COPD severity and ICS use were not linked to the lower airway microbiota.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thorax-2023-220455","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T18:50:41Z","timestamp":1707418241000},"page":"219-226","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Lower airway microbiota in COPD and healthy controls"],"prefix":"10.1136","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8060-5306","authenticated-orcid":false,"given":"Solveig","family":"Tangedal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Aanerud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Drengenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar R","family":"Huseb\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel S","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-5982","authenticated-orcid":false,"given":"Pieter S","family":"Hiemstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas ML","family":"Eagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"key":"2024051409182163000_79.3.219.1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.062802"},{"key":"2024051409182163000_79.3.219.2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-0409"},{"key":"2024051409182163000_79.3.219.3","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-216153"},{"key":"2024051409182163000_79.3.219.4","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-216494"},{"key":"2024051409182163000_79.3.219.5","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.01168","article-title":"Paradigms of lung microbiota functions in health and disease, particularly, in asthma","volume":"9","author":"Mathieu","year":"2018","journal-title":"Front Physiol"},{"key":"2024051409182163000_79.3.219.6","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207235"},{"key":"2024051409182163000_79.3.219.7","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01967-14"},{"key":"2024051409182163000_79.3.219.8","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.041822"},{"key":"2024051409182163000_79.3.219.9","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global Initiative for Chronic Obstructive Lung Disease. 2022."},{"key":"2024051409182163000_79.3.219.10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cmi.2022.11.029","article-title":"Hospitalization for chronic obstructive pulmonary disease and pneumonia: association with the dose of inhaled corticosteroids. A nation-wide cohort study of 52 100 outpatients","volume":"29","author":"R\u00f8nn","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2024051409182163000_79.3.219.11","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101312","article-title":"Inhaled corticosteroids and the lung microbiome in COPD","volume":"9","author":"Keir","year":"2021","journal-title":"Biomedicines"},{"key":"2024051409182163000_79.3.219.12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1164\/rccm.202102-0289OC","article-title":"Effects of inhaled corticosteroid\/long-acting \u03b22-agonist combination on the airway microbiome of patients with chronic obstructive pulmonary disease: a randomized controlled clinical trial (DISARM)","volume":"204","author":"Leitao Filho","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024051409182163000_79.3.219.13","doi-asserted-by":"crossref","DOI":"10.1038\/s41522-021-00185-9","article-title":"Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort","volume":"7","author":"Opron","year":"2021","journal-title":"NPJ Biofilms Microbiomes"},{"key":"2024051409182163000_79.3.219.14","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3389\/fmicb.2020.01758","article-title":"A refined view of airway microbiome in chronic obstructive pulmonary disease at species and strain-levels","volume":"11","author":"Wang","year":"2020","journal-title":"Front Microbiol"},{"key":"2024051409182163000_79.3.219.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016384","article-title":"Analysis of the lung microbiome in the \u201chealthy\u201d smoker and in COPD","volume":"6","author":"Erb-Downward","year":"2011","journal-title":"PLoS ONE"},{"key":"2024051409182163000_79.3.219.16","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-214168"},{"key":"2024051409182163000_79.3.219.17","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00019-2017","article-title":"Protected sampling is preferable in bronchoscopic studies of the airway microbiome","volume":"3","author":"Gr\u00f8nseth","year":"2017","journal-title":"ERJ Open Res"},{"key":"2024051409182163000_79.3.219.18","doi-asserted-by":"publisher","DOI":"10.3402\/ecrj.v3.33324"},{"key":"2024051409182163000_79.3.219.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068302","article-title":"Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing","volume":"8","author":"Zakharkina","year":"2013","journal-title":"PLoS One"},{"key":"2024051409182163000_79.3.219.20","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00015-2018","article-title":"Microbial and host immune factors as drivers of COPD","volume":"4","author":"Mika","year":"2018","journal-title":"ERJ Open Res"},{"key":"2024051409182163000_79.3.219.21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047305","article-title":"The lung microbiome in moderate and severe chronic obstructive pulmonary disease","volume":"7","author":"Pragman","year":"2012","journal-title":"PLoS One"},{"key":"2024051409182163000_79.3.219.22","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-208599"},{"key":"2024051409182163000_79.3.219.23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-83524-2","article-title":"Comparative analysis of the alveolar microbiome in COPD, ECOPD, Sarcoidosis, and ILD patients to identify respiratory illnesses specific microbial signatures","volume":"11","author":"Gupta","year":"2021","journal-title":"Sci Rep"},{"key":"2024051409182163000_79.3.219.24","doi-asserted-by":"crossref","unstructured":"Gr\u00f8nseth R , Haaland I , Wiker HG , et al . The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences. Eur Clin Respir J 2014;1. doi:10.3402\/ecrj.v1.26196","DOI":"10.3402\/ecrj.v1.26196"},{"key":"2024051409182163000_79.3.219.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2019-000449","article-title":"Complications and discomfort after research bronchoscopy in the MicroCOPD study","volume":"7","author":"Leiten","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"2024051409182163000_79.3.219.26","doi-asserted-by":"crossref","unstructured":"Hoang T , Wiker H , Mikal L Eagan T , et al . 16S amplicon PCR for the V3-V4 region for the microcopd samples v1. [Preprint] 2019. doi:10.17504\/protocols.io.2sygefw","DOI":"10.17504\/protocols.io.2sygefw"},{"key":"2024051409182163000_79.3.219.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033865","article-title":"Evaluation of methods for the extraction and purification of DNA from the human microbiome","volume":"7","author":"Yuan","year":"2012","journal-title":"PLoS One"},{"key":"2024051409182163000_79.3.219.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0209-9"},{"key":"2024051409182163000_79.3.219.29","unstructured":"R Foundation for Statistical Computing . R: A language and environment for statistical computing. 2020."},{"key":"2024051409182163000_79.3.219.30","doi-asserted-by":"crossref","unstructured":"Lin H , Peddada SD . Analysis of compositions of microbiomes with bias correction. Nat Commun 2020;11. doi:10.1038\/s41467-020-17041-7","DOI":"10.1038\/s41467-020-17041-7"},{"key":"2024051409182163000_79.3.219.31","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-021-04193-6","article-title":"Comparison study of differential abundance testing methods using two large Parkinson disease gut microbiome datasets derived from 16S amplicon sequencing","volume":"22","author":"Wallen","year":"2021","journal-title":"BMC Bioinformatics"},{"key":"2024051409182163000_79.3.219.32","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02114","article-title":"Analysis of microbiome data in the presence of excess zeros","volume":"8","author":"Kaul","year":"2017","journal-title":"Front Microbiol"},{"key":"2024051409182163000_79.3.219.33","unstructured":"Tangedal S , Aanerud M , et al . Data from the lower airway microbiota in COPD and healthy controls. Dryad Digital Repository 2023. doi:10.5061\/dryad.rfj6q57ff"},{"key":"2024051409182163000_79.3.219.34","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00037-15"},{"key":"2024051409182163000_79.3.219.35","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1016\/S2666-5247(21)00035-5","article-title":"Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis","volume":"2","author":"Ramsheh","year":"2021","journal-title":"Lancet Microbe"},{"key":"2024051409182163000_79.3.219.36","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200802-014ET"},{"key":"2024051409182163000_79.3.219.37","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01328-2016"},{"key":"2024051409182163000_79.3.219.38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1164\/rccm.202110-2241OC","article-title":"Lung microbiota and metabolites collectively associate with clinical outcomes in milder stage chronic obstructive pulmonary disease","volume":"206","author":"Madapoosi","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2024051409182163000_79.3.219.39","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00035-14"},{"key":"2024051409182163000_79.3.219.40","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01406-2015"},{"key":"2024051409182163000_79.3.219.41","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051110","article-title":"Inhaled corticosteroids selectively alter the microbiome and host transcriptome in the small airways of patients with chronic obstructive pulmonary disease","volume":"10","author":"Yip","year":"2022","journal-title":"Biomedicines"},{"key":"2024051409182163000_79.3.219.42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222449"},{"key":"2024051409182163000_79.3.219.43","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2017.1368848"},{"key":"2024051409182163000_79.3.219.44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90067-z","article-title":"Publisher correction: the effect of taxonomic classification by full-length 16S rRNA sequencing with a synthetic long-read technology","volume":"11","author":"Jeong","year":"2021","journal-title":"Sci Rep"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2023-220455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T16:20:52Z","timestamp":1715703652000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2023-220455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2,15]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/thorax-2023-220455"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2023-220455","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]}}}